I could be wrong, but I suspect that all of this money being thrown at research cloning could end up in a new “dot-com” type bust—only this time with public money since private investors are generally shunning investing in cloning companies.
This story that a pet cloning company has closed its doors adds credence to my views. Cloning is a difficult and expensive technology, even more so in humans than in animals. If after we “invest” billions into cloning research and it is a bust, who will pay the price? Taxpayers!
America's most
influential
journal of
religion and
public life
Subscribe
Latest Issue
Support First Things
influential
journal of
religion and
public life
Subscribe
Latest Issue
Support First Things